NCT01382472View on ClinicalTrials.gov

Microcirculation In Acute Coronary Syndromes

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
ST Elevation (STEMI) Myocardial Infarction
Interventions
DRUG

Rosuvastatin

40 mg per operative in PPCI, the 40 daily during hospital stay

DRUG

Simvastatin

No statin acutely. Simvastatin 20 mg from day 2.

Trial Locations (3)

4068

Stavanger University Hospital, Stavanger

NO-9038

University Hospital of North Norway, Tromsø

NO-7006

St. Olavs Hospital, Trondheim

All Listed Sponsors
collaborator

Helse Vest

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

St. Olavs Hospital

OTHER

lead

Helse Stavanger HF

OTHER_GOV

NCT01382472 - Microcirculation In Acute Coronary Syndromes | Biotech Hunter | Biotech Hunter